Cryo-Cell International Inc. (CCEL)
NYSE · Healthcare
Cryo-Cell International Inc. EBITDA 2010–2025
Cryo-Cell International Inc. annual/quarterly ebitda history and growth rate from 2010 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Cryo-Cell International Inc. ebitda for the quarter ending February 28, 2026 was 1.0 M, a 22.60% decrease year-over-year.
- Cryo-Cell International Inc. ebitda for the twelve months ending February 28, 2026 was 6.1 M, a 12.94% increase year-over-year.
- Cryo-Cell International Inc. annual ebitda for 2025 was 1.5 M, a 64.84% decrease from 2024.
- Cryo-Cell International Inc. annual ebitda for 2024 was 4.2 M, a 138.28% decrease from 2023.
- Cryo-Cell International Inc. annual ebitda for 2023 was -10.9 M, a 297.42% decrease from 2022.
- Cryo-Cell International Inc. annual ebitda for 2022 was 5.5 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cryo-Cell International Inc. EBITDA — FAQ
Cryo-Cell International Inc. (CCEL) ebitda over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CCEL's ebitda history?
The chart and table above show Cryo-Cell International Inc.'s ebitda by year and by quarter, including the growth rate.